Skip to main content
Mark Thornton, MD, Family Medicine, Damascus, MD

MarkOwensThorntonMD

Family Medicine Damascus, MD

Physician

Dr. Thornton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Thornton's full profile

Already have an account?

Education & Training

  • Johns Hopkins School of Public Health
    Johns Hopkins School of Public HealthM.P.H., Biostatistics, Epidemiology, 2000
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineFellowship, Clinical Pharmacology, 1994 - 1995
  • National Capital Consortium
    National Capital ConsortiumInternship, Transitional Year, 1987 - 1988
  • West Virginia University School of Medicine
    West Virginia University School of MedicineClass of 1987
  • West Virginia University
    West Virginia UniversityPh.D., Pharmacology & Toxicology, 1983

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1996 - 2025

Awards, Honors, & Recognition

  • Recipient of Paramount BioCapital "Leadership In Medical Excellence" Award 2004
  • Service Medal (Persian Gulf War) National Defense, 1991
  • Navy Commendation Medal 1991

Publications & Presentations

Journal Articles

  • EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phas...  
    Hecht JR, Farrell JJ, Senzer N, Neumunaitis J, Rosemurgy A, Chung T, Hanna N, Chang KJ, Javle M, Posner M, Waxman I, Reid A, Erickson R, Canto M, Chak M, Blatner G, Ko..., Gastrointest Endosc, 1/1/2012
  • Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer  
    Murugesan SR, King CR, Osborn R, Fairweather WR, O,Reilly EM, Thornton MO, Wei LL, Cancer Gene Ther, 1/1/2009
  • Human Immune Response to Pseudomonas aeruginosa Mucoid Exopolysaccharide (alginate) Vaccine  
    Pier G, DesJardins D, Grout M, Garner C, BennettS, Pekoe G, FullerS and Thornton, M, Infection and Immunity, 1/1/1994
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Safety and pharmacologic activity of the vasopressin antagonist OPC-41061 in healthy volunteers.
    Thornton M, Rahman M, Bramer S, Yamamura Y and Ingenito G, Meeting of the American College of Cardiology, Boca Raton, FL, 1/1/1997
  • Safety and immunogenicity of a Pseudomonas aeruginosa mucoid exopolysaccharide immunizing agent on a plasma donor population.
    Thornton M, Fuller S, Denio L, Polvent C, Garstka C, Krentz S, Propst M and Pier G, 94th General Meeting of the American Society for Microbiology, Las Vegas, NV, 1/23/1994
  • Safety and pharmacokinetics of a mucoid Pseudomonas aeruginosa immune globulin, intravenous (human) in patients with cystic fibrosis-Preliminary results of a Phase I/I...
    Moss R, Fink R, Schroeder S, Ramsey B, Fries L, Fuller S, Harkonen S. Muenz L and Thornton M, Eighth Annual North American CF Conference, Orlando, FL, 1/20/1994
  • Join now to see all

Other

  • Selected aspects oftriazolam in relation to aviator performance in Naval Flight operations. 
    Thornton M and Morey W, Technical Memorandum (Publications of the Naval Aerospace Medical Research Laboratory)
    1/1/1987
  • Pyridostigmine and warm water diving protoco190-05: III. 
    Thomas J, Schrot J, Ahlers S, Thornton M, Dutka A, Armstrong D, Kowalski K and Shurtleff D, Cognitive Performance Assessment Naval Medical Research Institute Technical Report (pp. 90-97)

Professional Memberships